Agilent Technologies (NYSE:A) Updates FY 2024 Earnings Guidance

Agilent Technologies (NYSE:A – Get Free Report) issued an update on its FY 2024 earnings guidance on Monday morning. The company provided EPS guidance of $5.44-$5.55 for the period, compared to the consensus EPS estimate of $5.41. The company issued revenue guidance of $6.71 billion-$6.81 billion, compared to the consensus revenue estimate of $6.82 billion. Agilent Technologies also updated its FY24 guidance to $5.44-5.55 EPS.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on A shares. TD Cowen upped their price target on Agilent Technologies from $145.00 to $147.00 and gave the stock an outperform rating in a report on Wednesday, August 16th. StockNews.com started coverage on shares of Agilent Technologies in a research note on Thursday, October 5th. They issued a buy rating for the company. Jefferies Financial Group dropped their price target on shares of Agilent Technologies from $150.00 to $146.00 and set a buy rating on the stock in a research report on Wednesday, August 16th. Evercore ISI reduced their price objective on shares of Agilent Technologies from $124.00 to $120.00 and set an in-line rating for the company in a research report on Wednesday, August 16th. Finally, Sanford C. Bernstein assumed coverage on shares of Agilent Technologies in a research report on Thursday, September 28th. They set a market perform rating and a $123.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have given a buy rating to the company. According to MarketBeat, Agilent Technologies has an average rating of Moderate Buy and a consensus price target of $143.94.

View Our Latest Stock Analysis on A

Agilent Technologies Trading Up 0.7 %

Want More Great Investing Ideas?

Shares of A traded up $0.83 during mid-day trading on Monday, reaching $113.98. The company’s stock had a trading volume of 2,935,927 shares, compared to its average volume of 1,824,513. The company has a current ratio of 2.29, a quick ratio of 1.68 and a debt-to-equity ratio of 0.49. Agilent Technologies has a 52 week low of $96.80 and a 52 week high of $160.26. The company’s fifty day moving average price is $109.96 and its two-hundred day moving average price is $117.80. The stock has a market cap of $33.35 billion, a PE ratio of 29.62, a P/E/G ratio of 2.01 and a beta of 1.04.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 24th. Shareholders of record on Tuesday, January 2nd will be paid a $0.236 dividend. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.23. This represents a $0.94 dividend on an annualized basis and a yield of 0.83%. The ex-dividend date is Friday, December 29th. Agilent Technologies’s payout ratio is 24.61%.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 3,500 shares of the business’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $118.78, for a total value of $415,730.00. Following the transaction, the vice president now owns 24,219 shares in the company, valued at $2,876,732.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.31% of the company’s stock.

Institutional Investors Weigh In On Agilent Technologies

Large investors have recently modified their holdings of the stock. Synovus Financial Corp lifted its position in Agilent Technologies by 2.3% during the first quarter. Synovus Financial Corp now owns 6,751 shares of the medical research company’s stock valued at $895,000 after buying an additional 153 shares during the period. Blair William & Co. IL grew its holdings in Agilent Technologies by 7.3% in the first quarter. Blair William & Co. IL now owns 28,606 shares of the medical research company’s stock worth $3,785,000 after purchasing an additional 1,957 shares during the period. Sequoia Financial Advisors LLC increased its stake in shares of Agilent Technologies by 52.1% during the first quarter. Sequoia Financial Advisors LLC now owns 2,334 shares of the medical research company’s stock valued at $309,000 after purchasing an additional 799 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Agilent Technologies by 1.1% during the first quarter. Vanguard Group Inc. now owns 24,531,170 shares of the medical research company’s stock valued at $3,246,209,000 after purchasing an additional 261,435 shares during the last quarter. Finally, Zions Bancorporation N.A. boosted its position in shares of Agilent Technologies by 10.8% in the 1st quarter. Zions Bancorporation N.A. now owns 2,880 shares of the medical research company’s stock worth $381,000 after purchasing an additional 281 shares in the last quarter. Institutional investors own 85.42% of the company’s stock.

About Agilent Technologies

(Get Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.